Contact Us

BUSINESS NEWS

CARsgen Announces the Initiation of an Investigator-Initiated Trial for an Allogeneic CD19/CD20 CAR-T Therapy

Jan 3, 2025

SHANGHAI,Dec. 31,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

WuXi Biologics Ranks Top in 2024 Dow Jones Sustainability Indices for Second Consecutive Year

Jan 3, 2025

Named for second consecutive year named to prestigious DJSI list Leading green biologics solutions for a healthier future

Malaysian SMEs Shine at the SME100 Awards 2024, Reflecting Growth and Resilience

Jan 3, 2025

KUALA LUMPUR,Malaysia,Jan. 2,2025-- Malaysian small and medium enterprises (SMEs) continue to demonstrate remarkable growth and resilience. For the 2024 SME100 Awards,the majority of winners hailed fr

CNOOC Limited Brings On-stream Panyu 11-12 Oilfield / Panyu 10-1 Oilfield / Panyu 10-2 Oilfield Adjustment Joint Development Project

Jan 3, 2025

HONG KONG,Jan. 2,2025-- CNOOC Limited (the "Company",SEHK: 00883 (HKD Counter) and 80883 (RMB Counter),SSE: 600938) today announces that Panyu 11-12 Oilfield/Panyu 10-1 Oilfield/Panyu 10-2

Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 Antibody Drug Conjugate

Jan 3, 2025

SAN FRANCISCO andSUZHOU,China,Jan. 2,2025-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high qual

NAVER D2SF-Backed GenGenAI Wins CES 2025 Innovation Award, Driving Global Growth with Unique Generative AI Synthetic Data Technology

Jan 3, 2025

Efficiently generates high-quality data essential for AI training and easily creates even specialized or hard-to-access data

1 ... 158 159 160 161 162 163 164 ... 382